- Home
- Publications
- Publication Search
- Publication Details
Title
Everolimus and sirolimus in transplantation-related but different
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 14, Issue 7, Pages 1055-1070
Publisher
Informa Healthcare
Online
2015-04-27
DOI
10.1517/14740338.2015.1040388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surgical complications after kidney transplantation: different impacts of immunosuppression, graft function, patient variables, and surgical performance
- (2015) Martina Koch et al. CLINICAL TRANSPLANTATION
- Cardiovascular risk assessment in kidney transplantation
- (2015) Allyson Hart et al. KIDNEY INTERNATIONAL
- Everolimus Inhibits Anti-HLA I Antibody-Mediated Endothelial Cell Signaling, Migration and Proliferation More Potently Than Sirolimus
- (2014) Y.-P. Jin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- De NovoSirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000-2003 Phase II Prospective Randomized Trial
- (2014) S. K. Asrani et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy
- (2014) D J Roberts et al. CELL DEATH AND DIFFERENTIATION
- Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation
- (2014) Damien Vitiello et al. Cellular & Molecular Immunology
- Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism
- (2014) Jelena Klawitter et al. PLoS One
- Focus on mTOR inhibitors and tacrolimus in renal transplantation: Pharmacokinetics, exposure–response relationships, and clinical outcomes
- (2014) Fuad Shihab et al. TRANSPLANT IMMUNOLOGY
- Strategies for the management of adverse events associated with mTOR inhibitors
- (2014) Bruce Kaplan et al. Transplantation Reviews
- A critical role for mTORC1 in erythropoiesis and anemia
- (2014) Zachary A Knight et al. eLife
- Cellular Effects of Everolimus and Sirolimus on Podocytes
- (2013) Sandra Müller-Krebs et al. PLoS One
- Longitudinal growth on an everolimus- versus an MMF-based steroid-free immunosuppressive regimen in paediatric renal transplant recipients
- (2013) Heiko Billing et al. TRANSPLANT INTERNATIONAL
- Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation
- (2013) V. Ram Peddi et al. Transplantation Reviews
- Safety and efficacy of everolimus- versus sirolimus-eluting stents: A systematic review and meta-analysis of 11 randomized trials
- (2012) Kyung Woo Park et al. AMERICAN HEART JOURNAL
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Everolimus in pediatric transplantation
- (2012) Lars Pape et al. Current Opinion in Organ Transplantation
- 650 High Rate of Discontinuation of a Mammalian Target of Rapamycin Inhibitor Based Regime during Long-Term Follow-Up of Cardiac Transplant Recipients
- (2012) J. González-Costello et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
- (2012) Rahul Bohra et al. PLoS One
- Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms
- (2012) Daniel C. Brennan et al. REVIEWS IN MEDICAL VIROLOGY
- The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats
- (2012) Cecilia M. Shing et al. TRANSPLANT INTERNATIONAL
- Drug Interaction Between Cyclosporine and mTOR Inhibitors in Experimental Model of Chronic Cyclosporine Nephrotoxicity and Pancreatic Islet Dysfunction
- (2012) Shang Guo Piao et al. TRANSPLANTATION
- Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
- (2012) Björn Nashan et al. TRANSPLANTATION
- Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor–Based Immunosuppression? A Systematic Review and Meta-Analysis
- (2012) Joachim Andrassy et al. TRANSPLANTATION
- Conversion from sirolimus to everolimus in kidney transplant recipients receiving a calcineurin-free regimen
- (2011) Catarina Carvalho et al. CLINICAL TRANSPLANTATION
- Inhibition of human in-stent restenosis: a molecular view
- (2011) Arturo Giordano et al. CURRENT OPINION IN PHARMACOLOGY
- Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors
- (2011) E. Vilar et al. MOLECULAR CANCER THERAPEUTICS
- Rapamycin passes the torch: a new generation of mTOR inhibitors
- (2011) Don Benjamin et al. NATURE REVIEWS DRUG DISCOVERY
- mTOR inhibition in kidney transplant recipients
- (2011) Sarah E. Yost et al. Nature Reviews Nephrology
- Surgical wound complications after heart transplantation
- (2011) Andreas Zuckermann et al. TRANSPLANT INTERNATIONAL
- Efficacy and Safety of Sirolimus and Everolimus in Heart Transplant Patients: A Retrospective Analysis
- (2011) B. Baur et al. TRANSPLANTATION PROCEEDINGS
- Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients
- (2010) H. Tedesco Silva Jr. et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunosuppressant Neurotoxicity in Rat Brain Models: Oxidative Stress and Cellular Metabolism
- (2010) Jelena Klawitter et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Use of sirolimus in liver transplant recipients with renal insufficiency: A systematic review and meta-analysis
- (2010) Sumeet K. Asrani et al. HEPATOLOGY
- The role of mTOR in memory CD8+ T-cell differentiation
- (2010) Koichi Araki et al. IMMUNOLOGICAL REVIEWS
- Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism
- (2010) Sven Gottschalk et al. NEUROTOXICOLOGY
- Comparative Analysis of Adverse Events Requiring Suspension of mTOR Inhibitors: Everolimus versus Sirolimus
- (2010) A.I. Sánchez-Fructuoso et al. TRANSPLANTATION PROCEEDINGS
- Clinical recommendations for the use of everolimus in heart transplantation
- (2010) Nicolás Manito et al. Transplantation Reviews
- Recent Developments in Kidney Transplantation-A Critical Assessment
- (2009) K. L. Womer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Association of Immunosuppressant-Induced Protein Changes in the Rat Kidney with Changes in Urine Metabolite Patterns: A Proteo-Metabonomic Study
- (2009) Jost Klawitter et al. JOURNAL OF PROTEOME RESEARCH
- Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial
- (2009) Paolo De Simone et al. LIVER TRANSPLANTATION
- Sirolimus and Everolimus Induced Pneumonitis in Adult Renal Allograft Recipients: Experience in a Center
- (2009) A. Rodríguez-Moreno et al. TRANSPLANTATION PROCEEDINGS
- The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation
- (2009) Juan F. Delgado et al. Transplantation Reviews
- Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients
- (2008) B. L. Kasiske et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Urine Metabolites Reflect Time-Dependent Effects of Cyclosporine and Sirolimus on Rat Kidney Function
- (2008) Jost Klawitter et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Decrease in sirolimus-induced proteinuria after switch to everolimus in a liver transplant recipient with diabetic nephropathy
- (2008) Martine Neau-Cransac et al. TRANSPLANT INTERNATIONAL
- Tolerance Profile of the Proliferation Signal Inhibitors Everolimus and Sirolimus in Heart Transplantation
- (2008) J.A. Moro et al. TRANSPLANTATION PROCEEDINGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started